Jason Zemansky
Stock Analyst at B of A Securities
(4.84)
# 72
Out of 4,944 analysts
40
Total ratings
78.57%
Success rate
37.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $94 → $109 | $122.87 | -11.29% | 10 | Jun 11, 2025 | |
| KROS Keros Therapeutics | Downgrades: Neutral | $32 → $18 | $13.90 | +29.50% | 2 | Jun 10, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $32 → $9 | $3.09 | +191.26% | 1 | May 28, 2025 | |
| CYTK Cytokinetics | Maintains: Neutral | $62 → $54 | $36.88 | +46.42% | 4 | Apr 15, 2025 | |
| TVTX Travere Therapeutics | Maintains: Buy | $29 → $31 | $18.05 | +71.75% | 4 | Apr 1, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $22 → $17 | $10.06 | +68.99% | 5 | Feb 19, 2025 | |
| KURA Kura Oncology | Maintains: Buy | $36 → $29 | $6.49 | +346.84% | 2 | Nov 22, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $30 → $31 | $13.45 | +130.48% | 3 | Aug 15, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $1.94 | +28.87% | 5 | Jun 20, 2024 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $1.35 | +640.74% | 4 | May 12, 2023 |
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $94 → $109
Current: $122.87
Upside: -11.29%
Keros Therapeutics
Jun 10, 2025
Downgrades: Neutral
Price Target: $32 → $18
Current: $13.90
Upside: +29.50%
Rocket Pharmaceuticals
May 28, 2025
Maintains: Buy
Price Target: $32 → $9
Current: $3.09
Upside: +191.26%
Cytokinetics
Apr 15, 2025
Maintains: Neutral
Price Target: $62 → $54
Current: $36.88
Upside: +46.42%
Travere Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $18.05
Upside: +71.75%
Arcus Biosciences
Feb 19, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $10.06
Upside: +68.99%
Kura Oncology
Nov 22, 2024
Maintains: Buy
Price Target: $36 → $29
Current: $6.49
Upside: +346.84%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $13.45
Upside: +130.48%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $1.94
Upside: +28.87%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.35
Upside: +640.74%